taurine has been researched along with Bacteremia in 22 studies
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment." | 9.14 | A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. ( Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D, 2010) |
| "Preliminary evidence from some studies suggests that taurolidine-citrate locks decrease catheter-related bacteremia (CRB), which is a major cause of morbidity and mortality in patients using intravascular catheters." | 8.90 | Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. ( Chen, L; Deng, J; Liu, H; Wu, Y; Yuan, L, 2014) |
| "Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment." | 5.14 | A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. ( Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D, 2010) |
| "Preliminary evidence from some studies suggests that taurolidine-citrate locks decrease catheter-related bacteremia (CRB), which is a major cause of morbidity and mortality in patients using intravascular catheters." | 4.90 | Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. ( Chen, L; Deng, J; Liu, H; Wu, Y; Yuan, L, 2014) |
| "Taurolidine is an antimicrobial agent that was originally used in the local treatment of peritonitis and was shown to be effective in the prevention of catheter-related bloodstream infections (CR-BSI)." | 2.71 | Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. ( Koldehoff, M; Zakrzewski, JL, 2004) |
| "Catheter-related bacteremia is a major cause of morbidity among hemodialysis patients." | 2.42 | Dialysis catheter-related bacteremia: treatment and prophylaxis. ( Allon, M, 2004) |
| "Taurolidine is a molecule with anti-endotoxic, anti-microbial and anti-inflammatory properties that inhibits bacterial adhesion, allowing for its use as lock therapy for the prevention of catheter-related bloodstream infections (CRBSI) in long-term central venous catheters (CVC)." | 1.62 | [Taurolidine for the prevention of catheter-related infections in children with intestinal insufficiency: preliminary experience in a Chilean tertiary hospital]. ( Haro, C; Jordán P, M; Puchi, A, 2021) |
| "Gentamicine was more effective than vancomycine." | 1.51 | In vitro comparison of efficacy of catheter locks in the treatment of catheter related blood stream infection. ( Blaha, V; Lasticova, M; Ryskova, L; Safranek, R; Visek, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Strauss, J | 1 |
| Boctor, DL | 1 |
| Silverman, JA | 1 |
| Casey, L | 1 |
| Jordán P, M | 1 |
| Haro, C | 1 |
| Puchi, A | 1 |
| Neusser, MA | 1 |
| Bobe, I | 1 |
| Hammermeister, A | 1 |
| Wittmann, U | 1 |
| Wouters, Y | 1 |
| Theilla, M | 1 |
| Singer, P | 1 |
| Tribler, S | 1 |
| Jeppesen, PB | 1 |
| Pironi, L | 1 |
| Vinter-Jensen, L | 1 |
| Rasmussen, HH | 1 |
| Rahman, F | 1 |
| Wanten, GJA | 1 |
| Clark, JE | 1 |
| Graham, N | 1 |
| Kleidon, T | 1 |
| Ullman, A | 1 |
| Visek, J | 1 |
| Ryskova, L | 1 |
| Safranek, R | 1 |
| Lasticova, M | 1 |
| Blaha, V | 1 |
| Chong, CY | 1 |
| Ong, RY | 1 |
| Seah, VX | 1 |
| Tan, NW | 1 |
| Chan, MY | 1 |
| Soh, SY | 1 |
| Ong, C | 1 |
| Lim, AS | 1 |
| Thoon, KC | 1 |
| Reitzel, RA | 1 |
| Rosenblatt, J | 1 |
| Chaftari, AM | 1 |
| Raad, II | 1 |
| Klek, S | 1 |
| Szczepanek, K | 1 |
| Hermanowicz, A | 1 |
| Galas, A | 1 |
| Saunders, J | 1 |
| Naghibi, M | 1 |
| Leach, Z | 1 |
| Parsons, C | 1 |
| King, A | 1 |
| Smith, T | 1 |
| Stroud, M | 1 |
| Liu, H | 2 |
| Deng, J | 1 |
| Chen, L | 1 |
| Yuan, L | 1 |
| Wu, Y | 1 |
| Murray, EC | 1 |
| Deighan, C | 1 |
| Geddes, C | 1 |
| Thomson, PC | 1 |
| Olthof, ED | 1 |
| Versleijen, MW | 1 |
| Huisman-de Waal, G | 1 |
| Feuth, T | 1 |
| Kievit, W | 1 |
| Wanten, GJ | 1 |
| Hulshof, EC | 1 |
| Hanff, LM | 1 |
| Olieman, J | 1 |
| de Vette, S | 1 |
| Driessen, GJ | 1 |
| Meeussen, C | 1 |
| Escher, JC | 1 |
| Weber, M | 1 |
| Meyer, F | 1 |
| Halloul, Z | 1 |
| Solomon, LR | 1 |
| Cheesbrough, JS | 1 |
| Ebah, L | 1 |
| Al-Sayed, T | 1 |
| Heap, M | 1 |
| Millband, N | 1 |
| Waterhouse, D | 1 |
| Mitra, S | 1 |
| Curry, A | 1 |
| Saxena, R | 1 |
| Bhat, R | 1 |
| Schulz, M | 1 |
| Diggle, P | 1 |
| Allon, M | 2 |
| Koldehoff, M | 1 |
| Zakrzewski, JL | 1 |
| Jurewitsch, B | 1 |
| Jeejeebhoy, KN | 1 |
| Willatts, SM | 1 |
| Speller, DC | 1 |
| Winter, RJ | 1 |
| Rosman, C | 1 |
| Westerveld, GJ | 1 |
| van Oeveren, W | 1 |
| Kooi, K | 1 |
| Bleichrodt, RP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Taurolidine 2% Catheter Locking to Prevent Catheter-related Bloodstream Infections in Patients on Home Parenteral Nutrition With a High Infection Risk and Those With a New Central Venous Access Device[NCT01826526] | 105 participants (Actual) | Interventional | 2013-06-30 | Completed | |||
| Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121] | 162 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| Short Daily Alcohol Locks for the Prevention of Tunneled Catheter Infection in Patients With Haematological Disease. Randomised Placebo Controlled Trial[NCT00122642] | Phase 2/Phase 3 | 440 participants (Anticipated) | Interventional | 2005-08-31 | Completed | ||
| [NCT00294502] | Phase 4 | 120 participants | Interventional | 2003-09-30 | Completed | ||
| The AOT (Acridine Orange and Taurolidine) Trial: a Survey on Diagnosis and Prevention of Catheter-Related Infections in Patients on Home Parenteral Nutrition[NCT00321165] | Phase 3 | 60 participants (Anticipated) | Interventional | 2006-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for taurine and Bacteremia
| Article | Year |
|---|---|
Epidemiology of Infectious and Noninfectious Catheter Complications in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infe | 2019 |
Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis.
Topics: Anti-Infective Agents; Anticoagulants; Bacteremia; Citric Acid; Female; Humans; Male; PubMed; Taurin | 2014 |
Dialysis catheter-related bacteremia: treatment and prophylaxis.
Topics: Antibiotic Prophylaxis; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Gentamic | 2004 |
7 trials available for taurine and Bacteremia
| Article | Year |
|---|---|
Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition.
Topics: Adult; Aged; Bacteremia; Catheter-Related Infections; Double-Blind Method; Equivalence Trials as Top | 2018 |
Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
Topics: Adolescent; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Central Venous | 2020 |
Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
Topics: Adult; Anti-Infective Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Veno | 2015 |
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Topics: Adult; Aged; Anti-Infective Agents; Anticoagulants; Bacteremia; Catheters, Indwelling; Citric Acid; | 2010 |
Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization; Catheters, Indwelling; F | 2003 |
Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization; Catheters, Indwelling; F | 2003 |
Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization; Catheters, Indwelling; F | 2003 |
Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization; Catheters, Indwelling; F | 2003 |
Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.
Topics: Adult; Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Female; Humans; Male; Neo | 2004 |
Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Critical Care; Double | 1994 |
12 other studies available for taurine and Bacteremia
| Article | Year |
|---|---|
Mechanical Complications in Central Lines Using Taurolidine Versus Ethanol Lock Therapy in Children With Intestinal Failure.
Topics: Bacteremia; Canada; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Cat | 2022 |
[Taurolidine for the prevention of catheter-related infections in children with intestinal insufficiency: preliminary experience in a Chilean tertiary hospital].
Topics: Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Child; Chile; Humans; Infa | 2021 |
A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
Topics: Bacteremia; Catheter-Related Infections; Central Venous Catheters; Equipment Failure; Humans; Renal | 2021 |
Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients.
Topics: Adolescent; Anti-Infective Agents, Local; Bacteremia; Catheter-Related Infections; Catheterization, | 2019 |
In vitro comparison of efficacy of catheter locks in the treatment of catheter related blood stream infection.
Topics: Anti-Bacterial Agents; Bacteremia; Candida; Catheter-Related Infections; Colony Count, Microbial; Eq | 2019 |
Taurolidine locks significantly reduce the incidence of catheter-related blood stream infections in high-risk patients on home parenteral nutrition.
Topics: Anti-Infective Agents, Local; Bacteremia; Catheter-Related Infections; Clinical Protocols; Humans; I | 2015 |
Taurolidine-citrate-heparin catheter lock solution reduces staphylococcal bacteraemia rates in haemodialysis patients.
Topics: Anti-Infective Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwe | 2014 |
Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.
Topics: Adult; Aged; Bacteremia; Catheter Obstruction; Catheter-Related Infections; Female; Heparin; Humans; | 2014 |
Taurolidine in Pediatric Home Parenteral Nutrition Patients.
Topics: Anti-Infective Agents; Bacteremia; Catheter-Related Infections; Child, Preschool; Humans; Infant; In | 2017 |
[Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
Topics: Adult; Aged; Anti-Infective Agents; Bacteremia; Bacterial Infections; Catheters, Indwelling; Device | 2009 |
Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections.
Topics: Adult; Anti-Infective Agents, Local; Bacteremia; Catheters, Indwelling; Humans; Middle Aged; Parente | 2005 |
Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats.
Topics: Abdomen; Animals; Anti-Bacterial Agents; Bacteremia; Bacteria; Body Fluids; Cilastatin; Colony Count | 1996 |